Whitehawk Therapeutics (WHWK) Other Accumulated Expenses (2016 - 2026)

Whitehawk Therapeutics (WHWK) has 10 years of Other Accumulated Expenses data on file, last reported at $106000.0 in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $106000.0 in Q1 2026; TTM through Mar 2026 was $106000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $106000.0, down 83.69% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $106000.0, roughly flat from $106000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for WHWK reached as high as $668000.0 in Q1 2022 and fell as low as $105000.0 in Q3 2025.
• Historically, Other Accumulated Expenses has averaged $291500.0 across 4 years, with a median of $110000.0 in 2025.
• Across the five-year window, Other Accumulated Expenses jumped 1774.67% in 2022 and sank 83.69% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $668000.0 in 2022, then slipped by 2.69% to $650000.0 in 2024, then sank by 83.69% to $106000.0 in 2025, then changed by 0.0% to $106000.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $106000.0 in Q1 2026, $106000.0 in Q4 2025, and $105000.0 in Q3 2025.